Similarly, RCCs in HLRCC, which is marked by dysregulated metabolism (fumarate accumulation) and HIF stabilization, have demonstrated sensitivity to metabolic strategies and VEGF/EGFR blockade. The gene discussed is VEGFA; the disease is hereditary leiomyomatosis and renal cell cancer.